Page 2 - Lara Longpre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lara longpre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lara Longpre Today - Breaking & Trending Today

JMP Securities Reaffirms "Market Outperform" Rating for Mirum Pharmaceuticals (NASDAQ:MIRM)

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by investment analysts at JMP Securities in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $64.00 price objective on the stock. JMP Securities’ price objective points to a potential upside of 142.15% from […] ....

Jolanda Howe , Raymond James , Lara Longpre , Eventide Asset Management , Morgan Stanley , Mirum Pharmaceuticals Company Profile , Mirum Pharmaceuticals Inc , Analyst Recommendations For Mirum Pharmaceuticals , Mirum Pharmaceuticals , Mirum Pharmaceuticals Stock , Securities Exchange Commission , Blackrock Inc , News Ratings For Mirum Pharmaceuticals Daily , Hedge Funds Weigh In On Mirum Pharmaceuticals , Jpmorgan Chase Co , Vanguard Group Inc , Get Free Report , Exchange Commission , Asset Management , Springs Capital Management , State Street Corp , Street Corp , Mirum Pharmaceuticals Daily , Nasdaq Mirm , Reiterated Rating , Jmp Securities ,

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Up to $31.00

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report)’s share price gapped up prior to trading on Wednesday . The stock had previously closed at $31.00, but opened at $32.28. Mirum Pharmaceuticals shares last traded at $32.35, with a volume of 70,778 shares changing hands. Analyst Upgrades and Downgrades Several equities analysts recently commented on MIRM […] ....

Lara Longpre , Peter Radovich , Raymond James , Panagora Asset Management Inc , Securities Exchange Commission , Hermes Inc , Mirum Pharmaceuticals Inc , Mirum Pharmaceuticals Company Profile , Prudential Financial Inc , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals Stock , Raymond James Financial Services Advisors Inc , Mirum Pharmaceuticals , Blackrock Inc , Get Free Report , Exchange Commission , James Financial Services Advisors , Asset Management , Prudential Financial , Mirum Pharmaceuticals Daily , Nasdaq Mirm ,

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Sees Large Growth in Short Interest

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Sees Large Growth in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Lara Longpre , Jolanda Howe , Raymond James , News Ratings For Mirum Pharmaceuticals Daily , Mirae Asset Global Investments Co , Clearbridge Investments , Swiss National Bank , Mirum Pharmaceuticals Price Performance , Mirum Pharmaceuticals Inc , Asset Management Inc , Mirum Pharmaceuticals Company Profile , Hedge Funds Weigh In On Mirum Pharmaceuticals , Mirum Pharmaceuticals , Tang Capital Management , Get Free Report , National Bank , Asset Management , Capital Management , Mirae Asset Global Investments , Mirum Pharmaceuticals Daily ,

Mirum Pharmaceuticals' (MIRM) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) in a report released on Friday morning, Benzinga reports. They currently have a $63.00 price objective on the stock. HC Wainwright also issued estimates for Mirum Pharmaceuticals’ Q2 2024 earnings at $0.23 EPS, Q3 2024 earnings at $0.38 EPS, Q4 […] ....

Lara Longpre , Christopher Peetz , Raymond James , Belpointe Asset Management , Mirum Pharmaceuticals , Endurance Wealth Management Inc , Group Plc , Mirum Pharmaceuticals Inc , Securities Exchange Commission , Institutional Investors Weigh In On Mirum Pharmaceuticals , Mirum Pharmaceuticals Stock Down , News Ratings For Mirum Pharmaceuticals Daily , Cubist Systematic Strategies , Brown Brothers Harriman Co , Free Report , Pharmaceuticals Stock Down , Exchange Commission , Wealth Management , Systematic Strategies , Asset Management , General Group Plc , Get Free Report , Mirum Pharmaceuticals Daily , Nasdaq Mirm , Reiterated Rating , Hc Wainwright ,

Raymond James Cuts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $79.00

Mirum Pharmaceuticals (NASDAQ:MIRM – Free Report) had its price target decreased by Raymond James from $82.00 to $79.00 in a research report released on Friday morning, Benzinga reports. Raymond James currently has a strong-buy rating on the stock. Separately, HC Wainwright upped their target price on Mirum Pharmaceuticals from $61.00 to $63.00 and gave the […] ....

Lara Longpre , Raymond James , Christopher Peetz , Prudential Financial Inc , Blackrock Inc , Hermes Inc , Securities Exchange Commission , News Ratings For Mirum Pharmaceuticals Daily , Mirum Pharmaceuticals , Panagora Asset Management Inc , Mirum Pharmaceuticals Stock Down , Mirum Pharmaceuticals Inc , Institutional Investors Weigh In On Mirum Pharmaceuticals , Insider Activity At Mirum Pharmaceuticals , Raymond James Financial Services Advisors Inc , Free Report , Pharmaceuticals Stock Down , Exchange Commission , James Financial Services Advisors , Asset Management , Prudential Financial , Get Free Report , Mirum Pharmaceuticals Daily , Nasdaq Mirm , Lower Price Target ,